Page 24 - Risk Evaluation News Today

Shan products banned in Germany due to ethylene oxide properties in it. So overseas desi people would have to find alternative

/PRNewswire/ -- The Bio-Process Systems Alliance (BPSA) announces the release of its latest guide, "X-Ray Sterilization of Single-Use Bioprocessing Equipment,...

The FDA approval of Leqembi, for Alzheimer disease, raises questions of safety and potential racial disparity in elder care.

The FDA on Thursday gave full approval to what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer’s disease.

Lecanemab, the new Alzheimer's drug approved by the FDA, is believed by many scientists to be the first to show promise in slowing the progression of dementia. But critics say its rollout will increase racial disparities because Black people tend to be diagnosed too late for the drug to be effective. Plus, few Black people were included in clinical trials, leading to safety concerns.

Collectively referred to as the "Transaction"). The Transaction constituted a reverse takeover of the Company by FTP under applicable securities laws. FTP became a...

Black patients and other minorities tend to be diagnosed at later stages of the disease, which would exclude them from use of Leqembi. Few Black people were included in the main trial of the drug.

This week the FDA is expected to approve what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer's disease.

US Environmental Protection Agency called for public nominations of 10 to 15 scientific, technical experts to review 2023 White Paper on Quantitative Human Health Approach to be Applied in Risk Evaluation for Asbestos Part 2, 88 Fed Reg 40819.

The use of a mainstay of the dry-cleaning industry – perchloroethylene – may be coming to an end.  On June 16, 2023, EPA proposed to ban, under the Toxic Substance Control Act’s Section...